Fujifilm

#Cell analysis #Fujifilm

FUJIFILM and NextCell launch commercial platform

FUJIFILM Biosciences and NextCell Pharma have announced the launch of a commercial research platform.  NextCell-Cord RUO combines FUJIFILM Biosciences’ PRIME-XV MSC Expansion XSFM medium and NextCell’s MSC product derived from umbilical cord tissue. The companies say the platform will provide researchers with a more consistent, efficient, and accessible source of cells. … Read More

#News

#Canada #Fujifilm #Japan

Collaboration to advance AAV production enhancers 

A Canadian Japanese co-innovation programme is set to advance AAV production enhancers.  AAV vectors are a cornerstone of in vivo gene delivery for gene therapies, but they remain difficult and expensive to manufacture at scale. As pipelines expand to more indications and broader patient populations, significantly greater amounts of… Read More

#News

#ABPI #Biomanufacturing #Cancer research #Clinical trial #Diabetes #European Union #FDA #Fujifilm #Oncology #Priority Review #Rare diseases #RNA #UK

DDW Highlights: 17 February 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers made a key discovery into cancer survival. Elsewhere, a global research effort… Read More

#Podcasts

#ABPI #Biomanufacturing #Cancer research #Clinical trial #Diabetes #European Union #FDA #Fujifilm #Oncology #Priority Review #Rare diseases #RNA #UK #United States

This week in Drug Discovery (9 – 13 February) 

News round-up for 9 – 13 February by Bruno Quinney, Content Team at DDW.  This week in DDW, researchers have made a key discovery into cancer survival. Elsewhere, a global research effort into kidney disease is underway.  The top stories:    Researchers identify RNA linked to cancer… Read More

#News

#Biomanufacturing #Fujifilm #NHS England #UK government

UK Chancellor hails FUJIFILM’s biomanufacturing expansion 

UK chancellor Rachel Reeves has hailed the expansion of FUJIFILM Biotechnologies facilities as “a vote of confidence in the UK”.  The Japanese company has expanded its facilities in the North East of England to support the biomanufacturing of innovative medicines and vaccines.  The company’s expanded… Read More

#News

#Biosciences #Fujifilm #Life sciences

FUJIFILM Irvine Scientific announces rebrand 

FUJIFILM Irvine Scientific has rebranded as FUJIFILM Biosciences, a decision the company hopes will build on FUJIFILM’s work in the life science industry.  FUJIFILM Biosciences has pledged to continue its customer-focus, empowering scientists and researchers at every stage of discovery, development, and commercialisation. By offering a products and services in cell culture… Read More

#Business & Investment #News

FDA headquarters
#Cancer research #Drug discovery #FDA #Fujifilm #Regulatory

FUJIFILM’s biliary tract cancer drug granted FDA orphan status

FUJIFILM Pharmaceuticals’ FF-10832—an investigational liposomal formulation of gemcitabine—has granted orphan drug designation for the treatment of biliary tract cancer (BTC) by the US Food and Drug Administration (FDA). FF-10832 is currently being evaluated in Phase IIa studies as monotherapy or in combination with pembrolizumab for the treatment of solid tumours… Read More

#Cancer Research #News